#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medullary thyroid cancer Cognitive disorder Haemophilia B with anti factor IX Rhabdomyosarcoma Liver abscess Pleomorphic leiomyosarcoma Short-bowel syndrome Rett syndrome Waldenstrom's macroglobulinaemia refractory Inclusion body myositis Hepatic angiosarcoma Selective polysaccharide antibody deficiency Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Acute graft versus host disease in skin Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Life with Disease Adrenogenital syndrome – Diagnostics Haemophilia A without inhibitors – Treatment Netherton’s syndrome – Basic Information Mucopolysaccharidosis I – Treatment Optic glioma – Diagnostics Breast angiosarcoma – Diagnostics Cholangitis sclerosing – Diagnostics Leiomyosarcoma – Trials in Disease Andersen-Tawil syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sym024 Vinflunine Rituximab Sodium Chloride Solution 0.9% Warfarin Potassium Chloride Tiotropium Bromide Monohydrate Osimertinib Istradefylline Envudeucitinib Elranatamab Ciclesonide ANERATRIGINE MESILATE Imiquimod Fidanacogene Elaparvovec Gozetotide Alf-18 Imipenem Monohydrate Domperidone Cendakimab Belimumab More therapies…

    Learn about Your Condition

    Breast cancer recurrent Dystonic tremor Nasopharyngeal cancer Oesophageal atresia Aplasia pure red cell Ectopic pregnancy Thalassaemia beta Metastatic gastric cancer Mitral valve prolapse Breast angiosarcoma Short stature Neuroblastoma Benign prostatic hyperplasia Coeliac disease Caesarean section More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sarcoma

  • Study of GSK5764227 Safety and Efficacy in Adults with Previously Treated Advanced Unresectable or Metastatic Sarcoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • GSK5764227
    France

  • Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • HER2 mutant non-small cell lung cancer
    • Sarcoma
    • Head and neck cancer
    Investigated Drugs:
    • Zanidatamab
    France

  • Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    • Malignant neoplasm of ampulla of Vater
    • Salivary gland cancer
    Investigated Drugs:
    • 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    • Bay 2927088
    • SEVABERTINIB
    Denmark France Italy Spain

  • Study on CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Advanced Sarcoma

    Recruiting

    1 1 1
    Investigated Drugs:
    • Cart45Ra-Nkg2D Cells
    Spain

  • Study of Activated NK Cells for Treating Sarcomas in Children, Adolescents, and Young Adults

    Recruiting

    2 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Allogeneic Peripheral Blood-Derived Cd56+ Natural Killer Cells, Co-Cultured With K562-Mb15-41Bbi Cell Line
    Spain

  • Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Sarcoma
    • Desmoplastic small round cell tumour
    Investigated Drugs:
    • Trabectedin
    • Irinotecan Hydrochloride Trihydrate
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!